Skip to main content
A

Ambalal Sarabhai Enterprise Ltd. — Investor Relations & Filings

Ticker · AMBALALSA ISIN · INE432A01017 BSE.NS Manufacturing
Open in API
Filings indexed 2 across all filing types
Latest filing 2026-04-21 Regulatory Filings
Country IN India
Listing BSE.NS AMBALALSA

About Ambalal Sarabhai Enterprise Ltd.

https://www.ase.life/

Ambalal Sarabhai Enterprise Ltd. is a diversified entity focused on the manufacturing and marketing of pharmaceutical products, fine chemicals, and diagnostic reagents. The organization operates through various divisions and subsidiaries, including Sarabhai Chemicals and Synbiotics Limited. Its core activities involve the production of bulk drugs, active pharmaceutical ingredients (APIs), and finished formulations across therapeutic categories such as antibiotics and vitamins. The company also provides veterinary healthcare products and specialized laboratory chemicals. Through its subsidiary Asence, it manages international marketing and distribution, targeting global healthcare markets. The enterprise maintains a focus on research-driven development to support its portfolio of medicinal products and industrial chemicals, serving both clinical and commercial sectors.

Recent filings

Filing Released Lang Actions
Format of the Annual Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars ....
Regulatory Filings Classification · 1% confidence The document is a compliance submission to BSE under SEBI circulars, providing an “Annual Disclosure” for large corporate entities. It does not fit any earnings, dividend, board change, capital raising, audit, or ESG categories. It’s a general regulatory disclosure to the stock exchange, so it falls under the fallback “Regulatory Filings” (RNS).
2026-04-21 English
Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details ....
Regulatory Filings Classification · 1% confidence The document is a formal letter to BSE Limited disclosing the non-applicability of specific SEBI circulars for the financial year. It is a compliance/regulatory announcement required under listing obligations rather than a financial report, management change, dividend notice, earnings release, or other specific category. This fits the fallback category for general regulatory announcements. Therefore, it is classified as a Regulatory Filing (RNS).
2026-04-21 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.